Log in to search using one of your social media accounts:

 

Transgene starts dosing in Phase Ib/II combination trial for HPV-positive cancers
Transgene has started dosing patients in a Phase Ib/II clinical trial of TG4001 in combination with avelumab to treat human papillomavirus type 16 positive (HPV-16+) recurrent or metastatic cancers. (Source: Drug Development Technology)
Source: Drug Development Technology - September 20, 2017 Category: Pharmaceuticals Source Type: news

Primary HPV Screening Detects More Lesions Than Cytology in Vaccinated Population (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Human papillomavirus (HPV) screening — compared with cytology-based screening — is associated with higher detection rates for precancerous cervical … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 20, 2017 Category: Primary Care Source Type: news

Screening for cervical abnormalities in women offered HPV vaccination
(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 19, 2017 Category: Cancer & Oncology Source Type: news

BU: HPV vaccine associated with improved fertility in some women
(Boston University School of Medicine) More than 40 percent of American teens are now getting vaccinated against human papillomavirus (HPV). But, despite HPV infection being associated with reduced semen quality and lower pregnancy rates, there is still public concern about whether the HPV vaccine itself could affect future fertility. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2017 Category: International Medicine & Public Health Source Type: news

Herd Immunity to HPV Emerging Among Young Women in the U.S. Herd Immunity to HPV Emerging Among Young Women in the U.S.
Human papillomavirus (HPV) infection is declining among young U.S. women, including those who have not received the vaccine, according to new research.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

USPSTF Draft Recommendation Eliminates Cervical Cytology-HPV Cotesting for Women Over 30 (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Women aged 30 –65 should undergo cervical cancer screening with either cervical cytology alone every 3 years or high-risk human papillomavirus … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

HPV vaccine may even protect women who never received it: Study
Fewer adult women are becoming infected with human papillomavirus, a trend that includes females who have never received the HPV vaccine, a new study reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 8, 2017 Category: Consumer Health News Source Type: news

HPV Vaccine May Even Protect Women Who Never Got It
FRIDAY, Sept. 8, 2017 -- Fewer adult women are becoming infected with human papillomavirus (HPV), a trend that includes females who have never received the HPV vaccine, a new study reports. It appears that enough women have gotten the HPV vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2017 Category: General Medicine Source Type: news

Improving cervical cancer screening rates for transgender men
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papillomavirus (HPV) testing, could improve the screening rate among transgender men. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

World Trade Center responders might face greater risk of HPV throat and tongue cancer
(Rutgers University) Researchers at Rutgers University -- investigating the causes of head and neck cancers in World Trade Center rescue and recovery workers -- will take the lead in a study to determine whether the responders are at a greater risk for human papillomavirus (HPV)-related throat and tongue cancer because of their exposure to toxic dust and debris. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Human papillomavirus 16 infections may pose variable cancer risk
(Cell Press) Human papillomavirus 16 accounts for about half of all cervical cancers, but researchers reporting Sept. 7 in the journal Cell have found that not all infections are equal. An analysis of the HPV16 genome from 5,570 human cell and tissue samples revealed that the virus actually consists of thousands of unique genomes, such that infected women living in the same region often have different HPV16 sequences and variable risks to cancer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 7, 2017 Category: Infectious Diseases Source Type: news

NAS, NAM Members Receive Lasker Awards
The Albert and Mary Lasker Foundation announced today that NAS member Michael N. Hall, professor, Biozentrum, University of Basel, Switzerland, is the recipient of the 2017 Albert Lasker Basic Medical Research Award for"discoveries concerning the nutrient-activated TOR proteins and their central role in the metabolic control of cell growth." Dual NAS/NAM member Douglas Lowy, acting director of the National Cancer Institute, has been awarded the 2017 Lasker~DeBakey Clinical Medical Research Award, along with John T. Schiller of the NCI, for"technological advances that enabled development of HPV vaccines for p...
Source: News from the National Academies - September 6, 2017 Category: Science Source Type: news

3 Scientists and Planned Parenthood Win Lasker Prizes for Medical Research
(NEW YORK) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards. The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium. The foundation’s clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical can...
Source: TIME.com: Top Science and Health Stories - September 6, 2017 Category: Consumer Health News Authors: Malcolm Ritter / AP Tags: Uncategorized awards medical research onetime Planned Parenthood Science Source Type: news

Lasker Prizes go to Planned Parenthood and Developers of HPV Vaccine
Prestigious awards come during a time of uncertainty for reproductive health care in the United States (Source: NYT Health)
Source: NYT Health - September 6, 2017 Category: Consumer Health News Authors: HEATHER MURPHY Tags: Lasker Awards Human Papillomavirus (HPV) Planned Parenthood Federation of America Lasker, Albert and Mary, Foundation Source Type: news

New study finds improved vaccine that protects against nine types of HPV
(H. Lee Moffitt Cancer Center& Research Institute) Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 6, 2017 Category: Cancer & Oncology Source Type: news

$1.8 million granted to YSPH to study effectiveness of HPV vaccine
A $1.8 million National Institutes of Health grant will help Yale researchers shed light on the real-world effectiveness of the Human Papillomavirus vaccine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 5, 2017 Category: Universities & Medical Training Source Type: news

New study finds improved vaccine that protects against nine types of HPV
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: World Pharma News)
Source: World Pharma News - September 5, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Few young cancer survivors are up to date with HPV vaccines
(Reuters Health) - Childhood cancer survivors in the U.S. are much less likely to have had human papillomavirus (HPV) vaccinations compared to their peers, despite being at increased risk from the virus, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - August 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Health Tip: Getting the HPV Vaccine
-- Human papillomavirus (HPV) is a sexually transmitted disease that has been linked to cancer of the cervix and a host of other cancers. The HPV vaccine is designed to prevent infection by the HPV-16 and HPV-18 strains of the virus, which are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2017 Category: General Medicine Source Type: news

Vaccine makers rely on "statistical gimmicks" to obscure the truth about HPV vaccines harming children
(Natural News) It has been more than a decade since Gardasil, the first ever vaccine specifically intended to prevent cancer, was approved for use by the FDA. At the time, Gardasil was touted as a miracle shot that would prevent young girls from being infected with the human papillomavirus (HPV), which causes genital warts, as... (Source: NaturalNews.com)
Source: NaturalNews.com - August 24, 2017 Category: Consumer Health News Source Type: news

More U.S. Teens Still Need To Get Vaccinated Against HPV
THURSDAY, Aug. 24, 2017 -- Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday. The bad news:... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2017 Category: General Medicine Source Type: news

More U.S. Teens Getting Vaccinated Against HPV
THURSDAY, Aug. 24, 2017 -- Six out of 10 U.S. parents are choosing to get their children vaccinated against the cancer-causing human papillomavirus (HPV), which is spread by sexual contact, federal health officials reported Thursday. The bad news:... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2017 Category: General Medicine Source Type: news

HPV vaccination rates lag for vulnerable population of childhood cancer survivors
(St. Jude Children's Research Hospital) Research suggests health providers are key to boosting HPV vaccination rates of childhood cancer survivors, who, as a group, are at increased risk for second cancers associated with the human papillomavirus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 24, 2017 Category: Cancer & Oncology Source Type: news

School nurses intimidating and pressuring young girls to get the HPV vaccine jab, even resorting to BULLYING tactics
(Natural News) The campaign group Alliance for Natural Health International (ANHI) recently claimed that schoolgirls who chose to opt out of human papillomavirus vaccination (HPV) were being subjected to pressure and bullying from nurses and school staff. According to the group, they have been receiving reports about tension between parents and school officials. The international organization also stressed that... (Source: NaturalNews.com)
Source: NaturalNews.com - August 22, 2017 Category: Consumer Health News Source Type: news

Inadvertent HPV Vaccination During Pregnancy Seems Safe Inadvertent HPV Vaccination During Pregnancy Seems Safe
Inadvertent human papillomavirus (HPV) vaccination in the periconceptional period or during pregnancy appears to have no adverse effects on women or their offspring, according to data from the Vaccine Safety Datalink.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Non-HPV Pap Smear Abnormalities More Common With Pelvic Organ Prolapse Non-HPV Pap Smear Abnormalities More Common With Pelvic Organ Prolapse
Non-human papillomavirus (HPV) abnormalities on Pap smear are more common in women with pelvic organ prolapse (POP) than in those without it, according to a chart review.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 7, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Class Action Lawsuit Against HPV Vaccine Filed in Colombia Class Action Lawsuit Against HPV Vaccine Filed in Colombia
An association representing 700 individuals who allege damage after receiving the human papillomavirus vaccine Gardasil has been launched in Colombia; a class action suit is ongoing in Japan.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 7, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students
Journal of Cancer Education pp 1 –8AbstractThe aim of this study is to assess dental students ’ opinions of the dentists’ role in primary prevention of human papillomavirus (HPV)-related oral cancer using a cross-sectional web-based survey. A questionnaire, containing questions about knowledge of HPV and oral cancer, confidence in head and neck examination and role of the dentist in preventing HPV-related oral cancer, was sent to all students of the Academic Centre of Dentistry Amsterdam (n = 912). One hundred and twenty-six (n = 126) students completed the questionnaire. Significantly...
Source: Dental Technology Blog - August 2, 2017 Category: Dentistry Source Type: news

Government committee declares HPV vaccines should never be given to teenage boys ... Media pursues total BLACKOUT on the story
(Natural News) A finding by the U.K.’s Joint Committee on Vaccination and Immunisation (JCVI), that it is not advisable to administer the human papillomavirus (HPV) vaccine to boys, has been met with absolute outrage and a virtual media blackout. Medical professionals in that country have been so indoctrinated by pharmaceutical companies to believe that this... (Source: NaturalNews.com)
Source: NaturalNews.com - July 26, 2017 Category: Consumer Health News Source Type: news

Preventing cancer with HPV vaccine
A vaccine exists that can actually prevent cancer, yet millions of people are not taking it. Dr. Tara Narula reports on how immunization against the human papillomavirus (or HPV) can prevent many cancers, but only two-thirds of girls and one-half of boys have received the vaccine. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 23, 2017 Category: Consumer Health News Source Type: news

Disappointment over interim ruling against HPV jab for boys
A decision by government advisors not to recommend extending routine immunisation against human papillomavirus (HPV) to teenage boys has been met with “disappointment” and “dismay”. (Source: Nursing Times)
Source: Nursing Times - July 19, 2017 Category: Nursing Source Type: news

Anal cancer can be caused by THIS virus - but the disease can have few symptoms
ANAL cancer is linked to a virus called the human papillomavirus - also known as HPV - which can be spread through sex. (Source: Daily Express - Health)
Source: Daily Express - Health - July 19, 2017 Category: Consumer Health News Source Type: news

How Common Are STIs?
Discussion Of the 30 different microbes which can be transmitted by sexual contact, 8 have the greatest incidence of transmitting disease. Four are curable (Chlamydia, Gonorrhea, Syphilis and Trichomoniasis) and 4 are incurable at present (Hepatitis B, Herpes simplex virus (HSV), Human immunodeficiency virus (HIV) and Human papillomavirus (HPV)). Sexually transmitted infections (STIs) are important as they can cause: Increased rates of acquisition of other STIs (ie HSV and syphilis increase the rate of HIV infection acquisition) Pelvic inflammatory disease and infertility Stillbirth and neonatal death Neonatal morbidity i...
Source: PediatricEducation.org - July 17, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

HPV Testing Speeds Cancer Diagnosis When Cytology Is Confusing HPV Testing Speeds Cancer Diagnosis When Cytology Is Confusing
Human papillomavirus (HPV) testing in women with cytology showing atypical squamous cells of undetermined significance (ASC-US) in the cervix leads to faster and more complete diagnosis, according to new research published in JAMA Oncology.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 29, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

HPV tests lead to earlier detection of cervical pre-cancer
Women who receive human papillomavirus (HPV) testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical pre-cancer, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - June 23, 2017 Category: Nursing Source Type: news

HPV testing leads to earlier detection and treatment of cervical pre-cancer
(Queen Mary University of London) Women who receive human papillomavirus (HPV) testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical precancer, according to a study of over 450,000 women by Queen Mary University of London (QMUL) and the University of New Mexico (UNM) Comprehensive Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news

HIV Tied to HPV Progression to Pre-cancerous Cervical Lesions HIV Tied to HPV Progression to Pre-cancerous Cervical Lesions
HIV-positive women are more likely than HIV-negative women to become infected with human papillomavirus (HPV) and to have that infection progress to high-grade lesions, a new report says.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 12, 2017 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant Sterile Suspension for Intramuscular Administratio) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 12, 2017 Category: Drugs & Pharmacology Source Type: news

Gardasil (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 12, 2017 Category: Drugs & Pharmacology Source Type: news

Inovio initiates Phase III trial of VGX-3100 to treat HPV-related cervical pre-cancer
Inovio Pharmaceuticals has initiated its Phase III REVEAL clinical programme of VGX-3100 for the treatment of cervical dysplasia associated with human papillomavirus (HPV), following a clinical hold removal by the US Food and Drug Administration (FDA … (Source: Drug Development Technology)
Source: Drug Development Technology - June 11, 2017 Category: Pharmaceuticals Source Type: news

Inovio launches late-stage cervical dysplasia trial after FDA lifts hold
Shares in Inovio Pharmaceuticals (NSDQ:INO) jumped more than 10% after it announced that it is launching a Phase III clinical study of its investigational DNA immunotherapy candidate designed to treat cervical dysplasia caused by human papillomavirus. The moves comes after the FDA lifted a hold that it placed on the clinical program in October last year. At the time, the FDA requested data to support the shelf-life of the disposable parts of Inovio’s Cellectra electroporation device. Get the full story at our sister site, Drug Delivery Business News.   The post Inovio launches late-stage cervical ...
Source: Mass Device - June 8, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Oncology Wall Street Beat Women's Health Inovio Pharmaceuticals Source Type: news

HIV-Positive Women Face Increased Risk of Precancerous Cervical Lesions
Women infected with the human immunodeficiency virus (HIV) are more likely to have human papillomavirus (HPV) infection that progresses to pre-cancerous cervical lesions. (Source: CancerNetwork)
Source: CancerNetwork - June 1, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Cervical Cancer Gynecologic Cancers News Source Type: news

HIV status may affect the progression of HPV infection to cervical pre-cancer
(American Association for Cancer Research) A study of Senegalese women showed that human papillomavirus (HPV) infection was more likely to develop into cervical pre-cancer in women living with human immunodeficiency virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2017 Category: International Medicine & Public Health Source Type: news

Immunotherapy with DNA vaccine shows promise for HPV-related head and neck cancer
(University of Pennsylvania School of Medicine) A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania. The treatment specifically targets human papillomavirus (HPV), which is frequently associated with HNSCCa, to trigger the immune response. Researchers will present the results of their pilot study during the 2017 American Society of Clinical Oncology Annual Meeting in Chicago (Abstract #6073). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 31, 2017 Category: Cancer & Oncology Source Type: news

2 Doses of HPV Shot Enough to Prevent Genital Warts: Study
Findings back up new CDC recommendations for kids (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - May 25, 2017 Category: Reproduction Medicine Tags: Infections, Reproductive Medicine, News, Source Type: news

2 Doses of HPV Shot Enough to Prevent Genital Warts
Findings back up new CDC recommendations for kids Source: HealthDay Related MedlinePlus Pages: Genital Warts, HPV, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 24, 2017 Category: Consumer Health News Source Type: news

2 Doses of HPV Shot Enough to Prevent Genital Warts: Study
WEDNESDAY, May 24, 2017 -- New research supports the recent U.S. recommendation for two, rather than three, doses of the human papillomavirus (HPV) vaccine to protect against genital warts in preteens and teens. Investigators at Boston University... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 24, 2017 Category: General Medicine Source Type: news

Shocking vaccine study finds that teens are being wildly overdosed with multiple HPV injections that do NOTHING to prevent genital warts
(Natural News) New research has shown that giving three doses of the HPV vaccine is essentially useless and provides no benefit to patients. It’s the first published evidence to support the CDC’s latest recommendation that two doses of the vaccine are more than sufficient to protect against genital warts for children between the ages of 11... (Source: NaturalNews.com)
Source: NaturalNews.com - May 23, 2017 Category: Consumer Health News Source Type: news

Pediatricians Give Parents Mixed Messages About HPV Vaccination Pediatricians Give Parents Mixed Messages About HPV Vaccination
Pediatricians often give parents mixed messages about the need for vaccination against human papillomavirus (HPV), according to a new analysis of audio recordings.Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 22, 2017 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

HPV vaccine protects men from oral cancer, study finds
The HPV vaccine does protect against infection, preventing genital warts, and possibly oral cancer in men, according to new studies. These are the first studies completed on the effects of the vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2017 Category: Consumer Health News Source Type: news